Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: Malignant Peripheral Nerve Sheath Tumors (MPNST) are rapidly progressing Schwann cell neoplasms. This study aimed to develop a practical clinical nomogram that predicts prognosis in patients with Head and Neck MPNST (HN-MPNST) using the Surveillance, Epidemiology, and End Results (SEER) database.
Methods: We extracted clinical data from patients with HN MPNST between 2000 and 2020 from the SEER database. Patients were randomly divided into training cohort and validation cohorts. To estimate the chance of survival in patients with HN MPNST, we developed a nomogram. The nomogram performance was evaluated by discrimination and calibration. In addition, a decision curve analysis was conducted to evaluate the clinical usefulness of this newly developed model. Molecular data highlighting the most frequent mutations in MPNST were obtained from the Catalogue Of Somatic Mutations In Cancer (COSMIC) database.
Results: In the primary cohort, 431 patients met the inclusion criteria to be entered into this study. The median Overall Survival (OS) was 3.9-years (95% CI 2.8-6.7), and the 1-, 3-, and 5-year OS rates were 75.2%, 52.6%, and 47.1%, respectively. We included 129 consecutive patients in the validation cohort. AJCC (American Joint Committee on Cancer) staging, Collaborative Stage (CS) extension, and CS tumor size were included in the nomogram. The calibration plots showed an agreement between the predictions and observations. Based on the clinical decision curve, the model had a net clinical benefit for patients with MPNST. Analysis of COSMIC data revealed frequent mutations of MPNST in NF1 (22%), SMARCB1 (21%), TP53 (12%), SUZ12 (19%), and less commonly in BRAF and CDKN2A (each 2%).
Conclusion: Radiotherapy improves survival in patients with metastatic disease or tumors ≥ 6 cm. Using this nomogram can assist in clinical decision making, as it has satisfactory accuracy. However, an additional external validation is required.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bjorl.2025.101702 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgical Measures Improving Functional Limitations of the Masticatory System, Aesthetic Deficits, and Skeletal Malformations in Neurofibromatosis Type 1-associated Hemifacial Diffuse Plexiform Neurofibroma Complicated by Rapidly Growing Midfacial Peripheral Nerve Sheath Tumor.
Cancer Diagn Progn
September 2025
Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Background/aim: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of multiple tumors, including plexiform neurofibromas (PNFs), which often affect the craniofacial region and cause significant functional and aesthetic impairments. This report presents long-term surgical management of a patient with hemifacial diffuse PNF, complicated by the emergence of a rapidly enlarging midfacial tumor.
Case Report: The patient was treated for hemifacial invasive diffuse plexiform neurofibroma.
Multimodal Intraoperative Neurophysiological Monitoring in Neurofibromatosis Type 1-Related Craniofacial Tumor Surgery.
J Craniofac Surg
September 2025
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China.
Objective: This study summarized the application effect and clinical experience of multimodal intraoperative neurophysiological monitoring (IONM) technology in the surgery of neurofibromatosis type 1 (NF1)-related craniofacial tumors.
Materials And Methods: A retrospective study was conducted on NF1 patients who were admitted between January 2019 and December 2024 and treated with craniofacial tumor resection surgery assisted by multimodal IONM technology. Data from this study were analyzed regarding sex, age at surgery, surgical procedures, IONM parameters, preoperative and postoperative symptoms, follow-up period, as well as oncological outcome.
Evaluating CAR-T cells from neurofibromatosis type 1 (NF1) patients for targeting AXL in malignant peripheral nerve sheath tumors associated with NF1.
Br J Cancer
September 2025
Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by neurofibromas, with 5-13% of patients risk developing malignant peripheral nerve sheath tumors (MPNST). Current treatments for MPNST are largely ineffective. AXL, overexpressed in MPNST, is a potential target for Chimeric Antigen Receptor T (CAR-T) cell therapy.
View Article and Find Full Text PDFMalignant peripheral nerve sheath tumor of the right forearm: Case report.
Int J Surg Case Rep
August 2025
Plastic and Reconstructive Surgery, Hospital Infantil de México, Federico Gómez, Mexico City, Mexico.
Introduction And Importance: Malignant peripheral nerve sheath tumor (MPNST), also called malignant schwannoma, neurofibrosarcoma and neurogenic sarcoma, is a malignant neoplastic lesion originating in the Schwann cells of the sheath lining of peripheral nerves.
Case Presentation: A 2-year-old, 7-month-old female patient, was admitted to our clinic due to progressive enlargement of the right forearm, physical examination revealed a tumor on the right forearm, painless, fixed to adjacent structures, hard, with erythema and swelling in the upper part of the lesion, complete surgical excision of the tumor with left inguinal graft was performed, covering the entire resected surgical defect. The pathology report was a malignant peripheral nerve sheath tumor.
Malignant peripheral nerve sheath tumor of the sigmoid colon: A case report and comparison with published cases.
Int J Surg Case Rep
August 2025
Department of Radiology, Faculty of Medicine and Health Science, Sana'a University, Sana'a City, Yemen.
Introduction: Malignant peripheral nerve sheath tumors (MPNSTs) are rare and aggressive soft tissue sarcomas. Its occurrence in the gastrointestinal tract, particularly in the sigmoid colon, is exceptionally uncommon and poses significant diagnostic and therapeutic challenges.
Case Presentation: We report the case of a 46-year-old female who presented with a four-year history of intermittent rectal bleeding and lower abdominal pain.